Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  New Frontier Health Corporation    NFH   KYG6461G1064

NEW FRONTIER HEALTH CORPORATION

(NFH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

New Frontier : Completes Acquisition of United Family Healthcare

12/19/2019 | 05:11am EST

Combined company renamed New Frontier Health Corporation and will trade on The New York Stock Exchange under 'NFH'.

Hong Kong, December 19, 2019 - New Frontier Corporation (NYSE: NFC) ('NFC'), a public investment vehicle sponsored by New Frontier Group, announced today that it has completed the acquisition of United Family Healthcare ('UFH'). UFH is one of the largest and most recognized integrated premium private healthcare operators in China. In connection with the closing, NFC has changed its name to New Frontier Health Corporation ('NFH'). NFH's ordinary shares and warrants will continue be listed on the New York Stock Exchange under the new ticker symbols 'NFH' and 'NFH WS,' respectively, commencing December 19, 2019.

UFH is one of the largest integrated private healthcare service providers in China, expecting to generate RMB2.5 billion in revenue in 2019. UFH currently owns and operates seven hospitals plus two under construction as well as 14 clinics in all four first tier cities and select second tier cities in China. The completion of this acquisition marks the latest milestone for NFH on the path towards delivering high quality and comprehensive healthcare services to ever more patients throughout China, and continuing to grow through organic expansion and strategic acquisitions.

UFH's senior management team, including Ms. Roberta Lipson, Founder and Chief Executive Officer of UFH, will continue to serve in their current roles. Mr. Antony Leung, Chairman of NFC, will continue as Chairman of NFH's board of directors. Mr. Qiyu Chen, Chairman of Fosun Pharma, will be Co-Chairman of NFH's board of directors. Mr. Carl Wu, Chief Executive Officer of NFC, will lead a new executive committee of the Company's board of directors to support and guide management for the continued success of NFH. The Company's board of directors consists of Mr. Antony Leung as Chairman, Mr. Carl Wu, Mr. Qiyu Chen, Ms. Roberta Lipson, Mr. Shan Fu, Mr. David Zeng, Dr. C.H. Leong, and Prof. Frederick Ma.

Transaction Details

NFC acquired UFH from its existing shareholders, including affiliates of TPG and Fosun Pharma. The acquisition was funded through a combination of cash in NFC's trust account, borrowings, and proceeds from the private placement of ordinary shares of NFH, led by premier institutional investors. Fosun Pharma will remain as an important long-term strategic partner.

The transaction provided NFH with approximately $165 million of additional capital, which is expected to be used for general corporate purposes, including for working capital and growth initiatives. As a result of the transaction, the combined company had an initial market capitalization of approximately $1.4 billion.

Credit Suisse and UBS AG served as capital markets advisors and Winston & Strawn LLP, Simpson Thacher & Bartlett LLP, Kirkland & Ellis LLP, and Global Law Office acted as legal advisors to NFC. Cleary Gottlieb Steen & Hamilton LLP and Fangda Partners acted as legal advisors to TPG, Paul Hastings acted as legal advisor to Fosun Pharma, and Hughes Hubbard & Reed LLP acted as legal advisor to Roberta Lipson.

About New Frontier Corporation

New Frontier Corporation is a public investment company formed by New Frontier Public Holding Ltd., an affiliate of New Frontier Group, for the purpose of entering into a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. New Frontier Group is a China-focused investment group that invests in, builds and operates diversified businesses in the Chinese new economy sectors. For more information, visit www.new-frontier.com.

About United Family Healthcare

United Family Healthcare (UFH) is a leading private healthcare provider offering comprehensive premium healthcare services in China through the operations of its United Family Healthcare platform, a network of private hospitals and affiliated ambulatory clinics. UFH currently owns and operates seven hospitals with over 700 licensed beds together with, a network of outpatient clinics as well as two more hospitals under construction, with locations in all four first tier and selected second tier cities Further company information may be found at www.ufh.com.cn.

Forward-Looking Statements

Certain statements made in this release are 'forward looking statements' within the meaning of the 'safe harbor' provisions of the United States Private Securities Litigation Reform Act of 1995. When used in this press release, the words 'estimates,' 'projected,' 'expects,' 'anticipates,' 'forecasts,' 'plans,' 'intends,' 'believes,' 'seeks,' 'may,' 'will,' 'should,' 'future,' 'propose' and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements. These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside NFH's control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. These forward-looking statements include, without limitation, UFH's ability to manage growth; UFH's ability to execute its business plan, including its planned expansions, and meet its projections; rising costs adversely affecting UFH's profitability; potential litigation involving NFH; general economic and market conditions impacting demand for UFH's services, and in particular economic and market conditions in the Chinese healthcare industry and changes in the rules and regulations that apply to such business, including as it relates to foreign investments in such businesses. NFH undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Contact:

ICR, LLC

Media

US:

Sean Leous

Tel: +1-203-682-8200

Email: sean.leous@icrinc.com

Asia:

Jeff Pei

Tel: +86-10-6583-7514

Email: jianfeng.pei@icrinc.com

Investors

William Zima/Rose Zu

Tel: +1-203-682-8200

Email: bill.zima@icrinc.com/rose.zu@icrinc.com

Disclaimer

New Frontier Corporation published this content on 19 December 2019 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 19 December 2019 10:10:01 UTC


© Publicnow 2019
All news about NEW FRONTIER HEALTH CORPORATION
2020NEW FRONTIER HEALTH : Download PDF PDF Format Download () PDF 6.86 MB
PU
2020NEW FRONTIER HEALTH : Q3 ()
PU
2020New Frontier Health's Fiscal Q3 Loss Narrows Year/Year Amid Revenue Growth; Q..
MT
2020NEW FRONTIER HEALTH CORPORATION : Announces Third Quarter 2020 Financial Results
BU
2020NEW FRONTIER HEALTH CORPORATION : to Announce Third Quarter of 2020 Financial Re..
BU
2020NEW FRONTIER HEALTH : Announces Second Quarter 2020 Financial Results
BU
2020NEW FRONTIER HEALTH : Healthcare to Announce Second Quarter of 2020 Financial Re..
BU
2020NEW FRONTIER HEALTH : Announces Executive Management Team Changes
BU
2020NEW FRONTIER HEALTH : Healthcare's United Family Healthcare Tops Ding Xiang Yuan..
BU
2020NEW FRONTIER HEALTH : Announces First Quarter 2020 Financial Results
BU
More news
Chart NEW FRONTIER HEALTH CORPORATION
Duration : Period :
New Frontier Health Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NEW FRONTIER HEALTH CORPORATION
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Average target price 84,85 CNY
Last Close Price 55,84 CNY
Spread / Highest target 75,3%
Spread / Average Target 52,0%
Spread / Lowest Target 28,6%
EPS Revisions
Managers and Directors
NameTitle
Roberta Lipson Chief Executive Officer & Director
Carl Wu President & Director
Kam Chung Leung Co-Chairman
Qi Yu Chen Co-Chairman
David Zeng Chief Operating Officer & Executive Director
Sector and Competitors